全文获取类型
收费全文 | 2638篇 |
免费 | 385篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 83篇 |
妇产科学 | 63篇 |
基础医学 | 332篇 |
口腔科学 | 33篇 |
临床医学 | 328篇 |
内科学 | 383篇 |
皮肤病学 | 48篇 |
神经病学 | 753篇 |
特种医学 | 210篇 |
外科学 | 272篇 |
综合类 | 58篇 |
一般理论 | 1篇 |
预防医学 | 164篇 |
眼科学 | 11篇 |
药学 | 211篇 |
中国医学 | 1篇 |
肿瘤学 | 89篇 |
出版年
2021年 | 34篇 |
2019年 | 18篇 |
2018年 | 36篇 |
2017年 | 23篇 |
2016年 | 28篇 |
2015年 | 34篇 |
2014年 | 46篇 |
2013年 | 85篇 |
2012年 | 98篇 |
2011年 | 114篇 |
2010年 | 88篇 |
2009年 | 96篇 |
2008年 | 111篇 |
2007年 | 120篇 |
2006年 | 130篇 |
2005年 | 112篇 |
2004年 | 121篇 |
2003年 | 95篇 |
2002年 | 83篇 |
2001年 | 90篇 |
2000年 | 91篇 |
1999年 | 68篇 |
1998年 | 59篇 |
1997年 | 61篇 |
1996年 | 58篇 |
1995年 | 58篇 |
1994年 | 45篇 |
1993年 | 50篇 |
1992年 | 75篇 |
1991年 | 71篇 |
1990年 | 52篇 |
1989年 | 78篇 |
1988年 | 59篇 |
1987年 | 64篇 |
1986年 | 42篇 |
1985年 | 48篇 |
1984年 | 31篇 |
1983年 | 28篇 |
1982年 | 28篇 |
1981年 | 37篇 |
1980年 | 27篇 |
1979年 | 37篇 |
1978年 | 38篇 |
1977年 | 23篇 |
1976年 | 22篇 |
1974年 | 20篇 |
1972年 | 22篇 |
1970年 | 16篇 |
1968年 | 15篇 |
1967年 | 16篇 |
排序方式: 共有3047条查询结果,搜索用时 0 毫秒
71.
John L. Reid DM Robert J. MacFadyen MD PhD Iain B. Squire MB Kennedy R. Lees MD 《The American journal of cardiology》1993,71(17):E57-E60
Angiotensin-converting enzyme (ACE) inhibitors improve survival in heart failure and delay progression to clinical heart failure in patients with left ventricular dysfunction after myocardial infarction. Increasing numbers of older patients are being considered for such treatment. However, there are reports of excessive and prolonged decreases in blood pressure (BP) after the first dose of some ACE inhibitors. We have studied the hemodynamics, pharmacokinetics, and neurohumoral responses to the first dose of oral captopril 6.25 mg, enalapril 2.5 mg, perindopril 2.0 mg, intravenous enalaprilat 1.5 mg, and perindoprilat 1.0 mg, compared with oral or intravenous placebo in 6 parallel groups of 12 elderly patients each with moderate-to-severe (New York Heart Association classes II-IV) heart failure. Oral dosing with active drugs led to different temporal responses. After captopril, there was an early short-lived decrease in BP. Enalapril led to a later long-lasting decrease, but perindopril was not different from placebo. Intravenous enalaprilat and intravenous perindoprilat each lowered BP to a similar extent. The doses of drugs used appeared to be comparable because plasma ACE inhibition was similar following perindopril or enalapril and also comparing perindoprilat and enalaprilat. These studies indicate that oral ACE inhibitors have different profiles of acute BP changes after the first dose. The explanation is not clear, but could include physicochemical differences in the interaction between prodrug ester and diacid metabolites leading to differences in tissue distribution and local enzyme inhibition. 相似文献
72.
73.
Background/Study Context: Typical measures for assessing the useful field (UFOV) of view involve many components of attention. The objective of the current experiment was to examine differences in visual search efficiency for older individuals with and without UFOV impairment. Methods: The authors used a computerized screening instrument to assess the useful field of view and to characterize participants as having an impaired or normal UFOV. Participants also performed two visual search tasks, a feature search (e.g., search for a green target among red distractors) or a conjunction search (e.g., a green target with a gap on its left or right side among red distractors with gaps on the left or right and green distractors with gaps on the top or bottom). Results: Visual search performance did not differ between UFOV impaired and unimpaired individuals when searching for a basic feature. However, search efficiency was lower for impaired individuals than unimpaired individuals when searching for a conjunction of features. Conclusion: The results suggest that UFOV decline in normal aging is associated with conjunction search. This finding suggests that the underlying cause of UFOV decline may arise from an overall decline in attentional efficiency. Because the useful field of view is a reliable predictor of driving safety, the results suggest that decline in the everyday visual behavior of older adults might arise from attentional declines. 相似文献
74.
75.
76.
Aoife P. Kiely Yasmine T. Asi Eleanna Kara Patricia Limousin Helen Ling Patrick Lewis Christos Proukakis Niall Quinn Andrew J. Lees John Hardy Tamas Revesz Henry Houlden Janice L. Holton 《Acta neuropathologica》2013,125(5):753-769
We report a British family with young-onset Parkinson’s disease (PD) and a G51D SNCA mutation that segregates with the disease. Family history was consistent with autosomal dominant inheritance as both the father and sister of the proband developed levodopa-responsive parkinsonism with onset in their late thirties. Clinical features show similarity to those seen in families with SNCA triplication and to cases of A53T SNCA mutation. Post-mortem brain examination of the proband revealed atrophy affecting frontal and temporal lobes in addition to the caudate, putamen, globus pallidus and amygdala. There was severe loss of pigmentation in the substantia nigra and pallor of the locus coeruleus. Neuronal loss was most marked in frontal and temporal cortices, hippocampal CA2/3 subregions, substantia nigra, locus coeruleus and dorsal motor nucleus of the vagus. The cellular pathology included widespread and frequent neuronal α-synuclein immunoreactive inclusions of variable morphology and oligodendroglial inclusions similar to the glial cytoplasmic inclusions of multiple system atrophy (MSA). Both inclusion types were ubiquitin and p62 positive and were labelled with phosphorylation-dependent anti-α-synuclein antibodies In addition, TDP-43 immunoreactive inclusions were observed in limbic regions and in the striatum. Together the data show clinical and neuropathological similarities to both the A53T SNCA mutation and multiplication cases. The cellular neuropathological features of this case share some characteristics of both PD and MSA with additional unique striatal and neocortical pathology. Greater understanding of the disease mechanism underlying the G51D mutation could aid in understanding of α-synuclein biology and its impact on disease phenotype. 相似文献
77.
78.
79.
Radiofrequency ablation of colorectal liver metastases 总被引:3,自引:2,他引:3
Background Untreated patients with colorectal liver metastases rarely survive 3 years, and the 3-year survival rate for patients treated with chemotherapy is 3%. The best survival rates are for the small subgroup that has operable disease, i.e., 39% at 5 years. Radiofrequency ablation (RFA) offers a new opportunity to destroy liver metastases in patients who are not surgical candidates because of disease distribution or comorbidity.Methods Acceptance criteria were a maximum of four or five liver lesions with a maximum diameter of 4 or 5 cm and no evidence of active extrahepatic disease. Nearly all treatments were performed percutaneously using ultrasound, computed tomography, or magnetic resonance imaging (or some combination) for guidance and monitoring. RFA is a minimally invasive procedure that can be readily repeated. General anesthesia facilitates the procedure but is not essential. Multiple overlapping ablations are required to ensure optimal treatment in all but the smallest tumors.Results In our cohort of 167 patients with colorectal liver metastases, 73 fulfilled the optimal acceptance criteria (5 or fewer tumors that were ≤ 5 cm). The median survival periods were 38 months, with a 5-year survival rate of 30%, after the diagnosis of liver metastases and 31 months, with a 5-year survival rate of 25%, after the first ablation.Conclusion RFA increases the therapeutic options for patients with colorectal metastases. Until controlled trials can better define the role of RFA, there are several groups of patients who are not surgical candidates and can be considered for RFA. 相似文献
80.
Joel Jakobsson Maria Bjerke Carl Johan Ekman Carl Sellgren Anette GM Johansson Henrik Zetterberg Kaj Blennow Mikael Landén 《Neuropsychopharmacology》2014,39(10):2349-2356
Bipolar disorder (BD) is characterized by mood swings between manic and depressive states. The etiology and pathogenesis of BD is unclear, but many of the affected cognitive domains, as well as neuroanatomical abnormalities, resemble symptoms and signs of small vessel disease. In small vessel disease, cerebrospinal fluid (CSF) markers reflecting damages in different cell types and subcellular structures of the brain have been established. Hence, we hypothesized that CSF markers related to small vessel disease may also be applicable as biomarkers for BD. To investigate this hypothesis, we sampled CSF from 133 patients with BD and 86 healthy controls. The concentrations of neurofilament light chain (NF-L), myelin basic protein (MBP), S100B, and heart-type fatty acid binding protein (H-FABP) were measured in CSF and analyzed in relation to diagnosis, clinical characteristics, and ongoing medications. Hereby we found an elevation of the marker of subcortical axonal damage, NF-L, in bipolar subjects. We also identified positive associations between NF-L and treatment with atypical antipsychotics, MBP and lamotrigine, and H-FABP and lithium. These findings indicate axonal damage as an underlying neuropathological component of bipolar disorder, although the clinical value of elevated NF-L remains to be validated in follow-up studies. The associations between current medications and CSF brain injury markers might aid in the understanding of both therapeutic and adverse effects of these drugs. 相似文献